Breaking News

Eurofins Amatsigroup Doubles Clinical Trial Supply Capacity

News comes after the Saint Gely du Fesc site's 2016 extension of its manufacturing areas

Eurofins Amatsigroup, a European CDMO, has doubled its clinical trial supply activities and capacities after major investments in its Saint Gely du Fesc, site, which specializes in packaging and logistics for human and veterinary drug products.

 

The new building has been designed to expedite the flow of drug products from reception to the distribution area, particularly for those sensitive to temperature. The facility will house seven packaging suites, and two secondary packaging rooms will be connected to a temperature-controlled storage area (2-8°C) to allow products to remain at the appropriate temperature during all processes. This enables products to be directly picked up in the cold chamber for shipment. 

 

With these new capacities, the Saint Gely du Fesc building will be able to manage the demand for primary packaging. Their capabilities offered include blistering for capsules, tablets, vials, syringes, and bottles.

 

“With the new capacities of storage, Eurofins Amatsigroup is positioned as a partner for depot activities, including project management, importation, storage, packaging, labeling and worldwide distribution to clinical sites,” said Stéphane Bronner, site director of Saint Gély du Fesc.

 

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters